ArticleCureus2026
A Repeated-Measures Study: Does Acute Exposure to Simulated Moderate Altitude Alter Wingate Performance and Skeletal Muscle Oxygenation Differently in Sprinters and Middle- and Long-Distance Runners?
Article in Cureus, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundAcute hypoxia may preserve initial explosive power while impairing power maintenance. This study examined graded acute simulated altitude effects on Wingate performance and vastus lateralis oxygenation in sprinters and middle- and long-distance (MD/LD) athletes.
methodsForty-four Indian sub-elite athletes, comprising 22 sprinters and 22 MD/LD athletes, completed a 30-second Wingate test under normoxia and simulated altitudes of 2000 m and 3000 m. At least 72 hours separated the trials. Muscle oxygenation was assessed using near-infrared spectroscopy. Data were analyzed using 2×3 mixed-design repeated-measures analysis of variance, Bonferroni-adjusted comparisons, and Spearman correlations.
resultsAt 3000 m, peak power decreased by 4.87-5.03%, average power by 7.24-9.84%, and minimum power by 11.78-15.72%. Power drop increased by 14.47-15.63%. Altitude significantly affected all Wingate outcomes (all p<0.001). The effects were largest for power drop (ηp²=0.972), minimum power (ηp²=0.954), and average power (ηp²=0.913), showing greater impairment of power maintenance. Group×altitude interactions were significant for average power (p<0.001), minimum power (p<0.001), and power drop (p=0.023), but not peak power (p=0.980). Oxygenated hemoglobin-myoglobin signal (O₂Hb), total hemoglobin (tHb), and tissue saturation index (TSI) decreased, whereas deoxygenated hemoglobin-myoglobin (HHb) increased (all altitude effects p<0.001; ηp²=0.950-0.998). At 3000 m, TSI was lower in sprinters than in MD/LD athletes (39.72±7.83% vs. 46.17±7.57%; adjusted p=0.025). Average power loss correlated with TSI change (ρ=-0.645; adjusted p<0.001) and HHb change (ρ=-0.707; adjusted p<0.001).
conclusionAcute simulated altitude impaired power maintenance and fatigue resistance more strongly than initial explosive power. Changes in TSI and HHb were associated with average power loss, particularly at 3000 m. These correlations do not establish causality. Sprinters and MD/LD athletes showed different response patterns, but neither group demonstrated a consistent overall advantage. Average power, minimum power, power drop, and muscle oxygenation may be considered together when evaluating anaerobic performance under hypoxic conditions.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.